Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Calpain inhibitor PD-150606 shows neuroprotective effects

Aug. 16, 1996

SmithKline Beecham takes over Bradycor development

Aug. 16, 1996

Taisho describes NGF production promotors

Aug. 16, 1996

GABA-A receptor ligands disclosed by Synthelabo

Aug. 16, 1996

Marinol potential in Alzheimer's disease patients reported at congress

Aug. 16, 1996

Sandoz announces Exelon pivotal study results

Aug. 16, 1996

NBI-5788 to enter clinical testing for M.S.

Aug. 16, 1996

Myotrophin expanded access program initiated

Aug. 16, 1996

Genetic insights into MS reported

Aug. 16, 1996

Pfizer investigates enantiomeric profiles of citalopram, fluoxetine

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 16, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...